Man Who Received Historic Pig Kidney Transplant Did Not Die From It
Doctors say that Richard Slayman's body did not reject a pig kidney modified to become more compatible with human biology.
InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...